Volume 121, Issue 2 , Pages 355-360, February 2008
Nitrative stress in refractory asthma
Background
Most asthma is mild and moderate and can be well controlled by low-dose inhaled steroid with or without bronchodilators. However, 5% to 10% of patients with asthma have more troublesome disease despite using such medication. Recent reports showed that nitrative stress induced tissue remodeling in vitro, which is associated with a component of refractoriness in asthma. However, there is no report that nitrative stress is involved in refractory asthma.
Objective
The aim of this study is to evaluate whether patients with refractory asthma have more nitrative stress.
Methods
Ten healthy subjects, 10 patients with well-controlled asthma, and 8 patients with refractory asthma took part in the current study. Exhaled nitric oxide, xanthine oxidase activity in the supernatant of the sputum, immunostaining for the inducible type of nitric oxide synthase, and 3-nitrotyrosine in induced sputum from the subjects were assessed.
Results
All nitrative markers including exhaled nitric oxide (P < .01), immunopositivities for inducible nitric oxide synthase (P < .01), xanthine oxidase activities (P < .01), and 3-nitrotyrosine (P < .01) in sputum from the refractory asthma group were enhanced compared with the well-controlled group. All these nitrative markers in the sputum had a significant negative correlation with the %FEV1 values (P < .01).
Conclusion
These results suggested that patients with refractory asthma have more nitrative stress in their airways compared with patients with well-controlled asthma.
Key words: Refractory asthma, induced sputum, steroids, nitrotyrosine, reactive oxygen species
Abbreviations used: eNO, Exhaled nitric oxide, HDAC 2, Histone deacetylase 2, ICS, Inhaled corticosteroid, iNOS, Inducible nitric oxide synthase, NO, Nitric oxide, RNS, Reactive nitrogen species, XO, Xanthine oxidase
Disclosure of potential conflict of interest: The authors have declared that they have no conflict of interest.
PII: S0091-6749(07)02220-8
doi:10.1016/j.jaci.2007.11.009
© 2008 American Academy of Allergy, Asthma & Immunology. Published by Elsevier Inc. All rights reserved.
Volume 121, Issue 2 , Pages 355-360, February 2008
